AU1620497A - Stable aqueous solubilizates of carotenoids and vitamins - Google Patents

Stable aqueous solubilizates of carotenoids and vitamins

Info

Publication number
AU1620497A
AU1620497A AU16204/97A AU1620497A AU1620497A AU 1620497 A AU1620497 A AU 1620497A AU 16204/97 A AU16204/97 A AU 16204/97A AU 1620497 A AU1620497 A AU 1620497A AU 1620497 A AU1620497 A AU 1620497A
Authority
AU
Australia
Prior art keywords
carotenoids
vitamins
stable aqueous
solubilizates
aqueous solubilizates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16204/97A
Inventor
Karl Kolter
Frank Runge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of AU1620497A publication Critical patent/AU1620497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU16204/97A 1996-03-11 1997-03-07 Stable aqueous solubilizates of carotenoids and vitamins Abandoned AU1620497A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19609477 1996-03-11
DE19609477A DE19609477A1 (en) 1996-03-11 1996-03-11 Stable aqueous solubilisates of carotenoids and vitamins

Publications (1)

Publication Number Publication Date
AU1620497A true AU1620497A (en) 1997-09-18

Family

ID=7787924

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16204/97A Abandoned AU1620497A (en) 1996-03-11 1997-03-07 Stable aqueous solubilizates of carotenoids and vitamins

Country Status (7)

Country Link
US (1) US5891907A (en)
EP (1) EP0800825A1 (en)
JP (1) JPH09249554A (en)
CN (1) CN1096264C (en)
AU (1) AU1620497A (en)
CA (1) CA2199415A1 (en)
DE (1) DE19609477A1 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653410A1 (en) 1996-12-20 1998-06-25 Basf Ag Use of carotenoid solubilisates for coloring food and pharmaceutical preparations
JP2002513411A (en) 1997-04-04 2002-05-08 ヘンケル コーポレーション Lutein ester with high bioavailability
AT408186B (en) * 1998-12-15 2001-09-25 Sanochemia Pharmazeutika Ag AQUEOUS PREPARATION OF BETA CAROTINE
JP2003511348A (en) * 1999-04-13 2003-03-25 レオ・ファーマ・アクティーゼルスカブ Solubilized pharmaceutical composition for parenteral administration
IN2000KO00299A (en) * 1999-05-28 2005-11-18 Johnson & Johnson Consumer
US6582721B1 (en) 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US8137699B2 (en) 2002-03-29 2012-03-20 Trustees Of Princeton University Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
DE10126446A1 (en) * 2001-05-31 2002-12-05 Cognis Deutschland Gmbh Hair care products with natural oils
US6635293B2 (en) * 2001-10-23 2003-10-21 Kemin Foods, L.C. Finely dispersed carotenoid suspensions for use in foods and a process for their preparation
DE10221212A1 (en) * 2002-05-13 2003-11-27 Andreas Maack Soluble composition containing sporopollenin and use
EP1526837A1 (en) * 2002-07-24 2005-05-04 Basf Aktiengesellschaft Ascorbic acid salt suspensions and use thereof as antioxidants
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
CN101845009B (en) * 2002-07-29 2012-10-03 卡达克斯药物公司 Structural carotenoid analogs for the inhibition and amelioration of disease
GB0218932D0 (en) * 2002-08-14 2002-09-25 Zoolife Internat Ltd Composition for dietary enrichment
DE10243437A1 (en) * 2002-09-18 2004-04-29 Pm-International Ag Cosmetic formulation
US20050037115A1 (en) * 2003-08-15 2005-02-17 Linda Fullmer Carotenoid nanodispersions for use in water-based systems and a process for their preparation
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
EP1750723A1 (en) * 2004-04-14 2007-02-14 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
EP1804788A4 (en) * 2004-10-25 2008-05-21 Sirion Therapeutics Inc Detection and analysis of ophthalmically-relevant fluorescent molecules
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
JP2007270073A (en) * 2006-03-31 2007-10-18 Fujifilm Corp Emulsion composition
US7435846B2 (en) * 2006-08-18 2008-10-14 Industrial Organica, S.A. De C.V. Absorption and bioavailability of carotenoids, formulations and applications
JP5046756B2 (en) * 2007-06-27 2012-10-10 富士フイルム株式会社 Dispersion composition, cosmetic for skin care, and method for producing dispersion composition
JP5019885B2 (en) * 2007-01-05 2012-09-05 富士フイルム株式会社 Dispersion composition, cosmetic for skin care, and method for producing dispersion composition
DK2111125T4 (en) 2007-01-16 2017-02-27 Basf Se LIQUID FORMULATIONS CONTAINING CAROTINOIDS
WO2008102019A2 (en) * 2007-02-23 2008-08-28 Basf Se Use of water-dispersible carotinoid nanoparticles as taste modulators, taste modulators containing water-dispersible carotinoid nanoparticles, and method for taste modulation
DE202008006492U1 (en) 2007-02-23 2008-08-21 Basf Se Use of water-dispersible carotenoid nanoparticles as taste modulators, flavor modulators containing water-dispersible carotenoid nanoparticles
ATE494800T1 (en) * 2007-02-23 2011-01-15 Brain Biotechnology Res & Information Network Ag METHOD FOR FLAVOR MODULATION OF MATERIAL COMPOSITIONS THAT CONTAIN AT LEAST ONE HIGH INTENSITY SWEETENER (HIS).
JP5101193B2 (en) * 2007-07-06 2012-12-19 富士フイルム株式会社 Cosmetic composition
DK2224823T4 (en) 2007-11-29 2022-02-21 Basf Se POWDERED CAROTINOIDE FOR COLORING BEVERAGES
JP5728152B2 (en) * 2008-07-07 2015-06-03 株式会社ファンケル Dry liposome preparation
EP2151231B1 (en) * 2008-08-05 2017-08-02 PM-International AG Cosmetic formulation
US9375387B2 (en) 2008-10-07 2016-06-28 Basf Se Ready-to-use, stable emulsion
ES2602812T3 (en) * 2008-12-01 2017-02-22 Aquanova Ag Micellarly integrated oxidation protection for natural dyes
FR2949063B1 (en) * 2009-08-11 2011-09-30 Pf Medicament PHARMACEUTICAL COMPOSITION COMPRISING A DHA ESTER FOR PARENTERAL ADMINISTRATION
US20120157547A1 (en) 2010-12-21 2012-06-21 Ricardo Montoya-Olvera Compositions and applications of carotenoids of improved absorption and bioavailability
US9849096B2 (en) 2013-03-28 2017-12-26 Omniactive Health Technologies Limited Neuroprotective effect of carotenoids in brain
AT514764A1 (en) 2013-09-02 2015-03-15 Sanochemia Ag Beta carotene preparation
US9622970B2 (en) * 2014-05-08 2017-04-18 Yaguang Liu Pharmaceutical composition containing lutein and antioxidant for treating and preventing human disease
AT521983A1 (en) * 2018-11-26 2020-06-15 Orphanix Gmbh Aqueous pediatric retinol preparations
EP3880168B1 (en) * 2018-11-26 2024-08-21 Orphanix GmbH Aqueous paediatric retinol formulations
CN111568858A (en) * 2020-04-30 2020-08-25 佛山科学技术学院 Preparation method of astaxanthin water solution
CN111991301A (en) * 2020-09-21 2020-11-27 四川梅奥由享生物科技有限公司 Emulsion with multiple effects of resisting inflammation, whitening, repairing and moisturizing
CN114081069A (en) * 2021-11-11 2022-02-25 光明乳业股份有限公司 Dairy product containing astaxanthin and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048000A1 (en) * 1980-12-19 1982-07-15 Basf Ag STABLE INJECTABLE (BETA) CAROTINE SOLUBILISATES AND METHOD FOR THE PRODUCTION THEREOF
DE4031094A1 (en) * 1990-10-02 1992-04-09 Basf Ag METHOD FOR PRODUCING STABLE INJECTABLE (BETA) CAROTINE SOLUBILISATES
GB9219524D0 (en) * 1992-09-15 1992-10-28 Smithkline Beecham Plc Novel composition
CH685325A5 (en) * 1994-01-04 1995-06-15 Marigen Sa Spontaneously dispersible carotene cpd. concentrate

Also Published As

Publication number Publication date
DE19609477A1 (en) 1997-09-18
EP0800825A1 (en) 1997-10-15
CN1165653A (en) 1997-11-26
US5891907A (en) 1999-04-06
CA2199415A1 (en) 1997-09-11
JPH09249554A (en) 1997-09-22
CN1096264C (en) 2002-12-18

Similar Documents

Publication Publication Date Title
AU1620497A (en) Stable aqueous solubilizates of carotenoids and vitamins
AU3574897A (en) Aqueous formulations of peptides
AU7177798A (en) Cosmetic preparations
AU4540697A (en) Photo-stable cosmetic and pharmaceutical formulations containing UV-filters
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU5799098A (en) Preparation of gabapentin
AU5520998A (en) Reduction of hair growth
AU3599597A (en) Reduction of hair growth
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
AU6729198A (en) Cosmetic preparations
AU3541697A (en) Use of artichoke (cynara) extracts
AU5730298A (en) Reduction of hair growth
AU7177698A (en) Cosmetic preparations
AU2578997A (en) Use of anthocyanidin and anthocyanidin derivatives
AU2670695A (en) Preparation of purines
AU3673497A (en) Detection of microbacteria
AU5339698A (en) Cyclohexanedione derivatives and herbicides containing them
EP0950098A4 (en) Stable expression of triple helical proteins
AU3118297A (en) Sok-1 and methods of use
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU5647096A (en) Combined preparations with vascular effect containing dihydr opyridines, acetylsalicylic acid nitroesters and vitamins
AU1637195A (en) Preparation of 3-mercaptopropionitrile and 3-mercaptopropionic acid
AU3964499A (en) Agouti-related protein analogs and methods of use
AU8750198A (en) Antibiotic preparations and use of the same
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use